Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease

doi:10.3748/wjg.15.1420

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2832)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

337

HTML

2256

Figures (1-1)

113

Tables (1-1)

126

Sum=2832

Mar 28, 2009 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Mar 28, 2009; 15(12): 1420-1426
Published online Mar 28, 2009. doi: 10.3748/wjg.15.1420

Open in New Tab Full Size Figure Download Figure

Figure 1 Thiopurine metabolism. For a caption to this figure please refer to metabolism and toxicity paragraphs and ref. 22. ¹TPMT is polymorphic and can be inhibited by mesalamine; ²Xanthine oxidase can be inhibited by allopurinol; ³ITPase is polymorphic.

Citation: Actis GC, Pellicano R, Rizzetto M, Ayoubi M, Leone N, Tappero G, Pazienza P, Rosina F. Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease. World J Gastroenterol 2009; 15(12): 1420-1426
URL: https://www.wjgnet.com/1007-9327/full/v15/i12/1420.htm
DOI: https://dx.doi.org/10.3748/wjg.15.1420